基于乳腺癌确诊后年数的筛查数字乳腺断层摄影性能指标
回顾性研究纳入8090例乳腺癌治疗后立即恢复筛查的患者共30812次筛查数字乳腺断层摄影,评估筛查性能指标与确诊后年数的关系。癌症检出率与确诊后年数呈独立正相关(校正OR 1.03),异常判读率呈独立负相关(校正OR 0.99),各年份异常判读率均低于10%。
要点
- 筛查数字乳腺断层摄影的癌症检出率为每1000次检查8.6例(265/30812),异常判读率为5.7%(1750/30812)。
- 癌症检出率与确诊后年数独立正相关(校正OR 1.03;95%CI 1.01-1.05;p<.001),>2至≤3年最低(每1000次4.9例),>8至≤9年最高(每1000次11.2例)。
- 异常判读率与确诊后年数独立负相关(校正OR 0.99;95%CI 0.98-1.00;p=.01),≤1年最高(7.5%),>5至≤6年最低(5.0%)。
核心结论
- 在8090例有乳腺癌病史的患者中,尽管确诊后1年内异常判读率高于后续年份,但所有年份的异常判读率均保持在可接受的低水平(<10%)。
研究设计与样本
- 回顾性研究,纳入2013年1月至2019年6月期间既往乳腺癌确诊后立即恢复筛查数字乳腺断层摄影的患者8090例(平均年龄65±11岁),共30812次筛查检查;采用广义估计方程的多变量logistic回归模型分析,控制年龄、种族和民族、乳腺密度、既往筛查乳腺摄影有无及判读放射科医师。
诊断标准与关键数值
- 癌症检出率为每1000次检查8.6例(265/30812)。
- 异常判读率为5.7%(1750/30812)。
- 阳性预测值1(PPV1)为15.1%(265/1750)。
- 敏感度为80.3%(265/330),特异度为95.1%(28997/30482),假阴性率为每1000次检查2.1例(65/30812)。
临床应用与阅片要点
- 癌症检出率与确诊后年数独立正相关(校正OR 1.03;95%CI 1.01-1.05;p<.001),>2至≤3年最低(每1000次4.9例),>8至≤9年最高(每1000次11.2例)。
- 异常判读率与确诊后年数独立负相关(校正OR 0.99;95%CI 0.98-1.00;p=.01),≤1年最高(7.5%),>5至≤6年最低(5.0%)。
- 作者指出这些结果支持研究机构对既往乳腺癌确诊患者立即恢复数字乳腺断层摄影筛查的乳腺摄影监测方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Mammography surveillance protocols after breast cancer treatment vary widely. Some practices recommend performing diagnostic mammography for a certain number of years or indefinitely, whereas others recommend returning immediately to screening. OBJECTIVE. This study's objective was to determine performance metrics of screening digital breast tomosynthesis (DBT) in patients who resume screening mammography immediately after breast cancer treatment, based on the number of years since the breast cancer diagnosis. METHODS. This retrospective study included screening DBT examinations performed from January 2013 to June 2019 in patients who resumed screening mammography immediately after a prior breast cancer diagnosis. Multivariable logistic regression models with generalized estimating equations were used to evaluate associations between screening performance metrics and years since the prior breast cancer diagnosis, controlling for age, race and ethnicity, breast density, presence of a prior screening mammogram, and interpreting radiologist. RESULTS. The study included 8090 patients (mean age, 65 ± 11 [SD] years) with a prior breast cancer diagnosis who underwent 30,812 screening DBT examinations during the study period. The cancer detection rate (CDR) was 8.6 per 1000 examinations (265/30,812), abnormal interpretation rate (AIR) was 5.7% (1750/30,812), PPV1 was 15.1% (265/1750), sensitivity was 80.3% (265/330), specificity was 95.1% (28,997/30,482), and false-negative rate was 2.1 per 1000 examinations (65/30,812). CDR showed a significant independent positive association with years since breast cancer diagnosis (adjusted OR, 1.03; 95% CI, 1.01-1.05; p < .001), being lowest more than 2 to up to 3 years after diagnosis (4.9 per 1000 examinations) and highest more than 8 to up to 9 years after diagnosis (11.2 per 1000 examinations). AIR showed a significant independent negative association with years since breast cancer diagnosis (adjusted OR, 0.99; 95% CI, 0.98-1.00; p = .01), being highest 1 year or less after diagnosis (7.5%) and lowest more than 5 to up to 6 years after diagnosis (5.0%). CONCLUSION. Among 8090 patients with a prior breast cancer diagnosis, even though the AIR was higher during the year after diagnosis compared with subsequent years, the AIR remained acceptably low (< 10%) in all years. CLINICAL IMPACT. These results support the study institution's mammographic surveillance protocol for patients with a prior breast cancer diagnosis of returning immediately to DBT screening.
引用
- Do D, Mercaldo S, Bahl M, et al. Performance Metrics of Screening Digital Breast Tomosynthesis Based on Years Since a Prior Breast Cancer Diagnosis. AJR Am J Roentgenol. 2023. PMID: 38117100. doi:10.2214/AJR.23.30419
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。